{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,27]],"date-time":"2026-03-27T21:08:05Z","timestamp":1774645685642,"version":"3.50.1"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,3,4]],"date-time":"2022-03-04T00:00:00Z","timestamp":1646352000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,3,4]],"date-time":"2022-03-04T00:00:00Z","timestamp":1646352000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100008070","name":"Department of Medicine, University of California, San Francisco","doi-asserted-by":"publisher","award":["The Robert L. Kroc Chair in Rheumatic"],"award-info":[{"award-number":["The Robert L. Kroc Chair in Rheumatic"]}],"id":[{"id":"10.13039\/100008070","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008070","name":"Department of Medicine, University of California, San Francisco","doi-asserted-by":"publisher","award":["Connective Tissue Diseases III"],"award-info":[{"award-number":["Connective Tissue Diseases III"]}],"id":[{"id":"10.13039\/100008070","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000069","name":"National Institute of Arthritis and Musculoskeletal and Skin Diseases","doi-asserted-by":"publisher","award":["R01-AR0703015"],"award-info":[{"award-number":["R01-AR0703015"]}],"id":[{"id":"10.13039\/100000069","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Orphanet J Rare Dis"],"published-print":{"date-parts":[[2022,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>COVID-19, caused by the SARS-CoV-2 virus, is a severe inflammatory condition. Patients with pre-existing conditions including diabetes, hypertension, and cardiovascular disease are at particularly high risk of complications. Fibrodysplasia ossificans progressiva (FOP) is an ultra-rare and debilitating genetic disorder that is characterized by a pro-inflammatory state, which leads to progressive heterotopic ossification and complications after trauma, including intramuscular vaccinations. To better understand the impact of COVID-19 on patients with FOP, we first examined the social impact of the pandemic using data from the FOP Registry managed by the International FOP Association. We also identified patients with FOP who were exposed to or contracted the SARS-CoV-2 virus, or who received a COVID-19 vaccine, to investigate if patients with FOP were at increased risks of complications from SARS-CoV2 exposure\u00a0or vaccination.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Data from 326 individuals in 69 countries in the International FOP Association FOP Connection Registry were examined\u00a0using patient-reported outcomes measurement information system (PROMIS) global health scale scores. Twenty-six (28.9%) participants aged\u2009\u2265\u200915\u00a0years old rated their satisfaction with their social activities and relationships as poor in 2020, which was an increase from 18 (18.9%) in 2019, prior to the SARS-CoV-2 outbreak. Similar trends were noted for physical and mental health in the pediatric population. Frequency of physician visits was not changed, but a larger portion of patients reported missing dental visits in 2020 compared with 2019 (31.5% vs. 41.7%). A second cohort with 32 subjects was tracked after SARS-CoV-2 exposure or vaccination. Ten subjects were positively diagnosed with COVID-19, 15 received a COVID-19 vaccine, and seven had high-risk SARS-CoV-2 exposure but either did not have a confirmed clinical diagnosis or tested negative. Subjects who tested positive for the virus showed no major complications or increased FOP disease activity, though our sample size is very limited. Among the 15 subjects who received a COVID-19 vaccine, using the International Clinical Council on FOP guidelines for prophylaxis with ibuprofen or acetaminophen, only one person experienced flare-like activity at the injection site.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Patients with FOP showed a significant decrease in social activities that was reflective of the isolation and mobility changes in this debilitated population. In our limited cohort, the majority of the patients with FOP who tested positive for COVID-19 showed no major complications. Also, although limited in sample size, the majority of patients who received a COVID-19 vaccination and followed guidelines from the FOP International Clinical Council tolerated vaccination well. Only one person experiencing flare activity following their injection. Thus, the risks and benefits of COVID-19 vaccination needs to be discussed carefully so as to support informed decisions.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s13023-022-02246-4","type":"journal-article","created":{"date-parts":[[2022,3,4]],"date-time":"2022-03-04T08:26:31Z","timestamp":1646382391000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Social and clinical impact of COVID-19 on patients with fibrodysplasia ossificans progressiva"],"prefix":"10.1186","volume":"17","author":[{"given":"Samuel","family":"Kou","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sammi","family":"Kile","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sai Samhith","family":"Kambampati","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Evelyn C.","family":"Brady","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hayley","family":"Wallace","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carlos M.","family":"De Sousa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kin","family":"Cheung","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lauren","family":"Dickey","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kelly L.","family":"Wentworth","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8924-106X","authenticated-orcid":false,"given":"Edward C.","family":"Hsiao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2022,3,4]]},"reference":[{"key":"2246_CR1","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/978-1-4939-2438-7_1","volume":"1282","author":"AR Fehr","year":"2015","unstructured":"Fehr AR, Perlman S. Coronaviruses: an overview of their replication and pathogenesis. Methods Mol Biol (Clifton, NJ). 2015;1282:1\u201323.","journal-title":"Methods Mol Biol (Clifton, NJ)"},{"issue":"11","key":"2246_CR2","doi-asserted-by":"publisher","first-page":"1061","DOI":"10.1001\/jama.2020.1585","volume":"323","author":"D Wang","year":"2020","unstructured":"Wang D, Hu B, Hu C, Zhu F, Liu X, Zhang J, et al. Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China. JAMA. 2020;323(11):1061\u20139.","journal-title":"JAMA"},{"key":"2246_CR3","unstructured":"Organization WH. COVID-19 weekly epidemiological update, edition 45, 22 June 2021. 2021."},{"issue":"1","key":"2246_CR4","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1002\/rmv.2146","volume":"31","author":"B Gallo Marin","year":"2021","unstructured":"Gallo Marin B, Aghagoli G, Lavine K, Yang L, Siff EJ, Chiang SS, et al. Predictors of COVID-19 severity: a literature review. Rev Med Virol. 2021;31(1):1\u201310.","journal-title":"Rev Med Virol"},{"issue":"10","key":"2246_CR5","doi-asserted-by":"publisher","first-page":"1217","DOI":"10.1017\/S1041610220000988","volume":"32","author":"TJ Hwang","year":"2020","unstructured":"Hwang TJ, Rabheru K, Peisah C, Reichman W, Ikeda M. Loneliness and social isolation during the COVID-19 pandemic. Int Psychogeriatr. 2020;32(10):1217\u201320.","journal-title":"Int Psychogeriatr"},{"issue":"1","key":"2246_CR6","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1016\/j.berh.2007.11.007","volume":"22","author":"FS Kaplan","year":"2008","unstructured":"Kaplan FS, Le Merrer M, Glaser DL, Pignolo RJ, Goldsby RE, Kitterman JA, et al. Fibrodysplasia ossificans progressiva. Best Pract Res Clin Rheumatol. 2008;22(1):191.","journal-title":"Best Pract Res Clin Rheumatol"},{"key":"2246_CR7","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1097\/01.blo.0000129557.38803.26","volume":"423","author":"RF Scarlett","year":"2004","unstructured":"Scarlett RF, Rocke DM, Kantanie S, Patel JB, Shore EM, Kaplan FS. Influenza-like viral illnesses and flare-ups of fibrodysplasia ossificans progressiva. Clin Orthop Relat Res. 2004;423:275\u20139.","journal-title":"Clin Orthop Relat Res"},{"issue":"5 Pt 1","key":"2246_CR8","doi-asserted-by":"publisher","first-page":"762","DOI":"10.1016\/S0022-3476(95)70408-6","volume":"126","author":"TF Lanchoney","year":"1995","unstructured":"Lanchoney TF, Cohen RB, Rocke DM, Zasloff MA, Kaplan FS. Permanent heterotopic ossification at the injection site after diphtheria-tetanus-pertussis immunizations in children who have fibrodysplasia ossificans progressiva. J Pediatr. 1995;126(5 Pt 1):762\u20134.","journal-title":"J Pediatr"},{"issue":"3","key":"2246_CR9","doi-asserted-by":"publisher","first-page":"650","DOI":"10.1002\/jbmr.2728","volume":"31","author":"RJ Pignolo","year":"2016","unstructured":"Pignolo RJ, Bedford-Gay C, Liljesthr\u00f6m M, Durbin-Johnson BP, Shore EM, Rocke DM, et al. The natural history of flare-ups in fibrodysplasia ossificans progressiva (FOP): a comprehensive global assessment. J Bone Miner Res: Off J Am Soc Bone Miner Res. 2016;31(3):650\u20136.","journal-title":"J Bone Miner Res: Off J Am Soc Bone Miner Res"},{"issue":"5","key":"2246_CR10","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1038\/ng1783","volume":"38","author":"EM Shore","year":"2006","unstructured":"Shore EM, Xu M, Feldman GJ, Fenstermacher DA, Brown MA, Kaplan FS. A recurrent mutation in the BMP type I receptor ACVR1 causes inherited and sporadic fibrodysplasia ossificans progressiva. Nat Genet. 2006;38(5):525\u20137.","journal-title":"Nat Genet"},{"key":"2246_CR11","doi-asserted-by":"crossref","unstructured":"Hatsell SJ, Idone V, Wolken DMA, Huang L, Kim HJ, Wang L, et al. ACVR1R206H receptor mutation causes fibrodysplasia ossificans progressiva by imparting responsiveness to activin A. Sci Transl Med. 2015;7(303):303ra137\u2013303ra137.","DOI":"10.1126\/scitranslmed.aac4358"},{"key":"2246_CR12","doi-asserted-by":"crossref","unstructured":"Barruet E, Morales BM, Cain CJ, Ton AN, Wentworth KL, Chan VT, et al. NF-\u03baB\/MAPK activation underlies ACVR1-mediated inflammation in human heterotopic ossification. JCI Insight. 2018;3(22).","DOI":"10.1172\/jci.insight.122958"},{"key":"2246_CR13","doi-asserted-by":"crossref","unstructured":"Matsuo K, Lepinski A, Chavez RD, Barruet E, Pereira A, Moody TA, et al. ACVR1R206H extends inflammatory responses in human induced pluripotent stem cell-derived macrophages. Bone. 2021.","DOI":"10.1016\/j.bone.2021.116129"},{"issue":"8","key":"2246_CR14","doi-asserted-by":"publisher","first-page":"1746","DOI":"10.1002\/jbmr.1637","volume":"27","author":"SA Chakkalakal","year":"2012","unstructured":"Chakkalakal SA, Zhang D, Culbert AL, Convente MR, Caron RJ, Wright AC, et al. An Acvr1 R206H knock-in mouse has fibrodysplasia ossificans progressiva. J Bone Miner Res: Off J Am Soc Bone Miner Res. 2012;27(8):1746\u201356.","journal-title":"J Bone Miner Res: Off J Am Soc Bone Miner Res"},{"issue":"2","key":"2246_CR15","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1002\/jbmr.3304","volume":"33","author":"MR Convente","year":"2018","unstructured":"Convente MR, Chakkalakal SA, Yang E, Caron RJ, Zhang D, Kambayashi T, et al. Depletion of mast cells and macrophages impairs heterotopic ossification in an Acvr 1(R206H) mouse model of fibrodysplasia ossificans progressiva. J Bone Miner Res: Off J Am Soc Bone Miner Res. 2018;33(2):269\u201382.","journal-title":"J Bone Miner Res: Off J Am Soc Bone Miner Res"},{"issue":"19","key":"2246_CR16","doi-asserted-by":"publisher","first-page":"5092","DOI":"10.1182\/blood-2010-09-306993","volume":"117","author":"E Sierra-Filardi","year":"2011","unstructured":"Sierra-Filardi E, Puig-Kr\u00f6ger A, Blanco FJ, Nieto C, Bragado R, Palomero MI, et al. Activin A skews macrophage polarization by promoting a proinflammatory phenotype and inhibiting the acquisition of anti-inflammatory macrophage markers. Blood. 2011;117(19):5092\u2013101.","journal-title":"Blood"},{"key":"2246_CR17","first-page":"1","volume":"2","author":"FS Kaplan","year":"2021","unstructured":"Kaplan FS, Al Mukaddam M, Baujat G, Brown M, Cali A, Cho T-J, et al. The medical management of fibrodysplasia ossificans progressiva: current treatment considerations. Proc Intl Clin Council FOP. 2021;2:1\u2013127.","journal-title":"Proc Intl Clin Council FOP"},{"issue":"3\u20134","key":"2246_CR18","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1385\/BMM:3:3-4:213","volume":"3","author":"FS Kaplan","year":"2005","unstructured":"Kaplan FS, Glaser DL. Thoracic insufficiency syndrome in patients with fibrodysplasia ossificans progressiva. Clin Rev Bone Miner Metab. 2005;3(3\u20134):213\u20136.","journal-title":"Clin Rev Bone Miner Metab"},{"issue":"1","key":"2246_CR19","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12891-019-3017-y","volume":"21","author":"S Singh","year":"2020","unstructured":"Singh S, Kidane J, Wentworth KL, Motamedi D, Morshed S, Schober AE, et al. Surgical management of bilateral hip fractures in a patient with fibrodysplasia ossificans progressiva treated with the RAR-\u03b3agonist palovarotene: a case report. BMC Musculoskelet Disord. 2020;21(1):1\u20138.","journal-title":"BMC Musculoskelet Disord"},{"issue":"9","key":"2246_CR20","doi-asserted-by":"publisher","first-page":"1544","DOI":"10.1093\/infdis\/jiab108","volume":"223","author":"E Synolaki","year":"2021","unstructured":"Synolaki E, Papadopoulos V, Divolis G, Tsahouridou O, Gavriilidis E, Loli G, et al. The activin\/follistatin axis is severely deregulated in COVID-19 and independently associated with in-hospital mortality. J Infect Diseases. 2021;223(9):1544.","journal-title":"J Infect Diseases."},{"key":"2246_CR21","doi-asserted-by":"crossref","unstructured":"McAleavy M, Zhang Q, Xu J, Pan L, Wakai M, Ehmann PJ. Activin A correlates with the worst outcomes in COVID-19 patients, and can be induced by cytokines via the IKK\/NF-kappa B pathway. bioRxiv. 2021:1\u201331.","DOI":"10.1101\/2021.02.04.429815"},{"issue":"2","key":"2246_CR22","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1016\/j.radcr.2020.12.002","volume":"16","author":"A Aziz","year":"2021","unstructured":"Aziz A, Choudhari R, Alexander AJ, Allam E. Heterotopic ossification post COVID-19: report of two cases. Radiol Case Reports. 2021;16(2):404\u20139.","journal-title":"Radiol Case Reports"},{"key":"2246_CR23","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1093\/qjmed\/hcab161","volume":"114","author":"IRB Godoy","year":"2021","unstructured":"Godoy IRB, Rodrigues TC, Skaf A. Myositis ossificans following COVID-19 vaccination. QJM: Int J Med. 2021;114:4\u20137.","journal-title":"QJM: Int J Med"},{"key":"2246_CR24","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1016\/j.bone.2017.08.032","volume":"109","author":"N Mantick","year":"2018","unstructured":"Mantick N, Bachman E, Baujat G, Brown M, Collins O, De Cunto C, et al. The FOP connection registry: design of an international patient-sponsored registry for fibrodysplasia ossificans progressiva. Bone. 2018;109:285\u201390.","journal-title":"Bone"},{"key":"2246_CR25","doi-asserted-by":"publisher","first-page":"115274","DOI":"10.1016\/j.bone.2020.115274","volume":"134","author":"RJ Pignolo","year":"2020","unstructured":"Pignolo RJ, Cheung K, Kile S, Fitzpatrick MA, De Cunto C, Al Mukaddam M, et al. Self-reported baseline phenotypes from the International Fibrodysplasia Ossificans Progressiva (FOP) Association Global Registry. Bone. 2020;134:115274.","journal-title":"Bone"},{"issue":"7","key":"2246_CR26","first-page":"873","volume":"18","author":"RD Hays","year":"2009","unstructured":"Hays RD, Bjorner JB, Revicki DA, Spritzer KL, Cella D. Development of physical and mental health summary scores from the patient-reported outcomes measurement information system (PROMIS) global items. Quality Res: Int J Quality Life Aspects Treat Care Rehabilit. 2009;18(7):873\u201380.","journal-title":"Quality Res: Int J Quality Life Aspects Treat Care Rehabilit"},{"key":"2246_CR27","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1016\/j.puhe.2017.07.035","volume":"152","author":"N Leigh-Hunt","year":"2017","unstructured":"Leigh-Hunt N, Bagguley D, Bash K, Turner V, Turnbull S, Valtorta N, et al. An overview of systematic reviews on the public health consequences of social isolation and loneliness. Public Health. 2017;152:157\u201371.","journal-title":"Public Health"},{"issue":"9","key":"2246_CR28","doi-asserted-by":"publisher","first-page":"837","DOI":"10.1089\/ars.2017.7312","volume":"28","author":"N Xia","year":"2018","unstructured":"Xia N, Li H. Loneliness, social isolation, and cardiovascular health. Antioxid Redox Signal. 2018;28(9):837\u201351.","journal-title":"Antioxid Redox Signal"},{"issue":"1","key":"2246_CR29","doi-asserted-by":"publisher","first-page":"18643","DOI":"10.1038\/s41598-021-97136-3","volume":"11","author":"K Yamada","year":"2021","unstructured":"Yamada K, Wakaizumi K, Kubota Y, Murayama H, Tabuchi T. Loneliness, social isolation, and pain following the COVID-19 outbreak: data from a nationwide internet survey in Japan. Sci Rep. 2021;11(1):18643.","journal-title":"Sci Rep"},{"issue":"1","key":"2246_CR30","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1097\/MLR.0000000000001448","volume":"59","author":"P Chatterji","year":"2021","unstructured":"Chatterji P, Li Y. Effects of the COVID-19 pandemic on outpatient providers in the United States. Med Care. 2021;59(1):58\u201361.","journal-title":"Med Care"},{"issue":"1","key":"2246_CR31","doi-asserted-by":"publisher","first-page":"e2143160","DOI":"10.1001\/jamanetworkopen.2021.43160","volume":"5","author":"DT Myran","year":"2022","unstructured":"Myran DT, Cantor N, Rhodes E, Pugliese M, Hensel J, Taljaard M, et al. Physician health care visits for mental health and substance use during the COVID-19 Pandemic in Ontario, Canada. JAMA Netw Open. 2022;5(1):e2143160.","journal-title":"JAMA Netw Open"},{"issue":"10282","key":"2246_CR32","doi-asserted-by":"publisher","first-page":"1331","DOI":"10.1016\/S0140-6736(21)00625-5","volume":"397","author":"T Shakespeare","year":"2021","unstructured":"Shakespeare T, Ndagire F, Seketi QE. Triple jeopardy: disabled people and the COVID-19 pandemic. Lancet (London, England). 2021;397(10282):1331\u20133.","journal-title":"Lancet (London, England)"},{"key":"2246_CR33","doi-asserted-by":"publisher","first-page":"79","DOI":"10.12688\/wellcomeopenres.15833.1","volume":"5","author":"H Kuper","year":"2020","unstructured":"Kuper H, Banks LM, Bright T, Davey C, Shakespeare T. Disability-inclusive COVID-19 response: What it is, why it is important and what we can learn from the United Kingdom\u2019s response. Wellcome Open Res. 2020;5:79.","journal-title":"Wellcome Open Res"},{"issue":"8","key":"2246_CR34","doi-asserted-by":"publisher","first-page":"e10181","DOI":"10.1002\/jbm4.10181","volume":"3","author":"K Peng","year":"2019","unstructured":"Peng K, Cheung K, Lee A, Sieberg C, Borsook D, Upadhyay J. Longitudinal evaluation of pain, flare-up, and emotional health in fibrodysplasia ossificans progressiva: analyses of the international FOP registry. JBMR Plus. 2019;3(8):e10181.","journal-title":"JBMR Plus."},{"issue":"8","key":"2246_CR35","doi-asserted-by":"publisher","first-page":"1495","DOI":"10.1007\/s00296-021-04911-6","volume":"41","author":"L Grgurevic","year":"2021","unstructured":"Grgurevic L, Novak R, Hrkac S, Salai G, Grazio S. Post-COVID-19 exacerbation of fibrodysplasia ossificans progressiva with multiple flare-ups and extensive heterotopic ossification in a 45-year-old female patient. Rheumatol Int. 2021;41(8):1495\u2013501.","journal-title":"Rheumatol Int"}],"container-title":["Orphanet Journal of Rare Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13023-022-02246-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13023-022-02246-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13023-022-02246-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,4]],"date-time":"2022-03-04T08:37:25Z","timestamp":1646383045000},"score":1,"resource":{"primary":{"URL":"https:\/\/ojrd.biomedcentral.com\/articles\/10.1186\/s13023-022-02246-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,3,4]]},"references-count":35,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,12]]}},"alternative-id":["2246"],"URL":"https:\/\/doi.org\/10.1186\/s13023-022-02246-4","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-885603\/v1","asserted-by":"object"}]},"ISSN":["1750-1172"],"issn-type":[{"value":"1750-1172","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,3,4]]},"assertion":[{"value":"8 September 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 February 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 March 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was approved by the Institutional Review Board at the University of California (approval number 20-30734). Subjects were consented to this protocol. Physicians also provided anonymous data separate from the consent of subjects. The FOP Registry was approved by the central institutional review board, Advarra (approval number CR00263401). Participants gave their consent to participate in the FOP Registry.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate:"}},{"value":"Written consent for publication of the clinical images was obtained from the subject.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"ECH serves in a volunteer capacity on the Medical Registry Advisory Board of the International Fibrodysplasia Ossificans Progressiva Association. ECH serves in a volunteer capacity on the Fibrous Dysplasia Foundation Medical Advisory Board. ECH is a member of the International Clinical Council on FOP. ECH, EB, SSK, CDS, and LD receive clinical trials support from Clementia Pharmaceuticals, an Ipsen Company. ECH received prior funding from Regeneron Pharmaceuticals and Neurocrine Biosciences for clinical trial activities. S Kile and KC are supported by the International FOP Association. These pose no conflicts for this study.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"107"}}